A detailed history of Gradient Investments LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Gradient Investments LLC holds 51 shares of EW stock, worth $4,645. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51
Previous 635 91.97%
Holding current value
$4,645
Previous $48,000 91.67%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$72.54 - $95.56 $42,363 - $55,807
-584 Reduced 91.97%
51 $4,000
Q4 2023

Jan 18, 2024

SELL
$61.71 - $77.76 $35,483 - $44,712
-575 Reduced 47.52%
635 $48,000
Q3 2023

Oct 27, 2023

BUY
$69.28 - $93.38 $67,548 - $91,045
975 Added 414.89%
1,210 $83,000
Q2 2023

Jul 11, 2023

BUY
$81.41 - $94.33 $4,477 - $5,188
55 Added 30.56%
235 $22,000
Q3 2022

Oct 14, 2022

SELL
$82.37 - $107.29 $3,130 - $4,077
-38 Reduced 17.43%
180 $15,000
Q2 2022

Jul 11, 2022

BUY
$86.5 - $128.27 $3,892 - $5,772
45 Added 26.01%
218 $21,000
Q3 2021

Oct 18, 2021

BUY
$102.91 - $122.75 $1,337 - $1,595
13 Added 8.13%
173 $20,000
Q1 2021

Apr 21, 2021

BUY
$78.68 - $90.67 $12,588 - $14,507
160 New
160 $13,000
Q1 2020

Apr 07, 2020

SELL
$52.41 - $81.0 $104 - $162
-2 Closed
0 $0
Q3 2019

Oct 10, 2019

BUY
$61.55 - $75.43 $123 - $150
2 New
2 $0
Q1 2019

Apr 11, 2019

SELL
$47.89 - $64.05 $5,028 - $6,725
-105 Closed
0 $0
Q4 2018

Jan 18, 2019

SELL
$46.41 - $56.94 $2,042 - $2,505
-44 Reduced 29.53%
105 $16,000
Q3 2018

Oct 11, 2018

SELL
$45.7 - $58.03 $271,549 - $344,814
-5,942 Reduced 97.55%
149 $26,000
Q2 2018

Aug 09, 2018

BUY
$42.45 - $51.3 $31,752 - $38,372
748 Added 14.0%
6,091 $887,000
Q1 2018

Apr 11, 2018

BUY
$37.19 - $47.45 $27,074 - $34,543
728 Added 15.77%
5,343 $745,000
Q4 2017

Feb 07, 2018

BUY
$33.79 - $39.39 $42,879 - $49,985
1,269 Added 37.93%
4,615 $520,000
Q3 2017

Oct 16, 2017

BUY
$36.29 - $38.83 $121,426 - $129,925
3,346
3,346 $366,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $56.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Gradient Investments LLC Portfolio

Follow Gradient Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.